DK156825C - Analogifremgangsmaade til fremstilling af en basisk ether eller et farmaceutisk acceptabelt syreadditionssalt eller kvaternaert salt deraf - Google Patents
Analogifremgangsmaade til fremstilling af en basisk ether eller et farmaceutisk acceptabelt syreadditionssalt eller kvaternaert salt derafInfo
- Publication number
- DK156825C DK156825C DK528980A DK528980A DK156825C DK 156825 C DK156825 C DK 156825C DK 528980 A DK528980 A DK 528980A DK 528980 A DK528980 A DK 528980A DK 156825 C DK156825 C DK 156825C
- Authority
- DK
- Denmark
- Prior art keywords
- preparing
- acid addition
- acceptable acid
- salt
- pharmaceutical acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HUEE002715 | 1979-12-14 | ||
| HU79EE2715A HU179164B (en) | 1979-12-14 | 1979-12-14 | Process for producing cycloalkyl-ethers of alkanolamines |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK528980A DK528980A (da) | 1981-06-15 |
| DK156825B DK156825B (da) | 1989-10-09 |
| DK156825C true DK156825C (da) | 1990-03-12 |
Family
ID=10995882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK528980A DK156825C (da) | 1979-12-14 | 1980-12-11 | Analogifremgangsmaade til fremstilling af en basisk ether eller et farmaceutisk acceptabelt syreadditionssalt eller kvaternaert salt deraf |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US4342762A (fi) |
| JP (1) | JPS56123953A (fi) |
| AT (1) | AT374449B (fi) |
| AU (1) | AU539173B2 (fi) |
| BE (1) | BE886579A (fi) |
| CA (1) | CA1155115A (fi) |
| CH (1) | CH649986A5 (fi) |
| CS (1) | CS216544B2 (fi) |
| DD (1) | DD155320A5 (fi) |
| DE (1) | DE3047142C2 (fi) |
| DK (1) | DK156825C (fi) |
| ES (1) | ES8200857A1 (fi) |
| FI (1) | FI76783C (fi) |
| FR (1) | FR2471968B1 (fi) |
| GB (1) | GB2065122B (fi) |
| GR (1) | GR72509B (fi) |
| HU (1) | HU179164B (fi) |
| IE (1) | IE51733B1 (fi) |
| IL (1) | IL61685A (fi) |
| IT (1) | IT1209377B (fi) |
| NL (1) | NL193907C (fi) |
| NO (1) | NO150638C (fi) |
| PL (1) | PL127036B1 (fi) |
| SE (1) | SE451132B (fi) |
| SU (1) | SU1253425A3 (fi) |
| UA (1) | UA5566A1 (fi) |
| YU (1) | YU42367B (fi) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5242934A (en) * | 1992-03-02 | 1993-09-07 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
| US5212188A (en) * | 1992-03-02 | 1993-05-18 | R. J. Reynolds Tabacco Company | Method for treatment of neurodegenerative diseases |
| US5242935A (en) * | 1992-03-06 | 1993-09-07 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
| US5227385A (en) * | 1992-03-13 | 1993-07-13 | Wake Forest University | Method for treatment of neurodegenerative diseases |
| US5288872A (en) * | 1992-03-13 | 1994-02-22 | Wake Forest University | Compounds for treatment of neurodegenerative diseases |
| US5276043A (en) * | 1992-04-10 | 1994-01-04 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
| US5214060A (en) * | 1992-04-10 | 1993-05-25 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
| US5187169A (en) * | 1992-04-10 | 1993-02-16 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
| US5232932A (en) * | 1992-05-21 | 1993-08-03 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
| US5242916A (en) * | 1992-07-07 | 1993-09-07 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
| US5248690A (en) * | 1992-07-07 | 1993-09-28 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
| JPH0626170A (ja) * | 1992-07-09 | 1994-02-01 | Yodogawa Steel Works Ltd | 壁板材の取付構造 |
| JPH06193226A (ja) * | 1992-12-26 | 1994-07-12 | Yodogawa Steel Works Ltd | 壁板材の取付構造 |
| US5652270A (en) * | 1994-07-01 | 1997-07-29 | Egis Gyogyszergyar Rt | Pharmaceutical compositions containing bicycloheptane ether amines and a process for the preparation thereof |
| HU214588B (hu) * | 1994-07-01 | 1998-04-28 | EGIS Gyógyszergyár Rt. | Eljárás bicikloheptán-származékot tartalmazó, CCK-rendszer gátló hatású gyógyászati készítmények előállítására |
| KR100381558B1 (ko) * | 1994-07-01 | 2003-08-19 | 에지스 지오기스제르기아르 알티. | 약제조성물및이의제조방법 |
| US5583140A (en) * | 1995-05-17 | 1996-12-10 | Bencherif; Merouane | Pharmaceutical compositions for the treatment of central nervous system disorders |
| HU226061B1 (en) * | 1996-10-17 | 2008-04-28 | Egis Gyogyszergyar Nyilvanosan | 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation |
| HUP9900445A2 (hu) * | 1999-02-24 | 2001-06-28 | EGIS Gyógyszergyár Rt. | Eljárás (1R,2S,4R)-(-)-N,N-(dimetilamino-etoxi)-2-fenil-1,7,7-trimetil-biciklo[2.2.1]heptán előállítására és ennek köztiterméke |
| HU227114B1 (en) * | 1999-05-11 | 2010-07-28 | Egis Gyogyszergyar Nyilvanosan | (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same |
| FI20002612A0 (fi) * | 2000-11-28 | 2000-11-28 | Orion Yhtymae Oyj | Yhdistelmäterapia serotoniinivälityksen häiriöiden hoitamiseksi |
| US6335372B1 (en) * | 2000-11-28 | 2002-01-01 | Orion Corporation | Treatment of obsessive compulsive disorder |
| HUP0103017A3 (en) * | 2001-07-18 | 2004-05-28 | Egis Gyogyszergyar Nyilvanosan | Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use |
| GB0306604D0 (en) * | 2003-03-21 | 2003-04-30 | Curidium Ltd | Second medical use |
| US20040192754A1 (en) * | 2003-03-24 | 2004-09-30 | Shapira Nathan Andrew | Methods for treating idiopathic hyperhidrosis and associated conditions |
| HUP0301537A3 (en) * | 2003-06-03 | 2005-07-28 | Egis Gyogyszergyar Nyilvanosan | Deramcyclane fumarate tablets and process for producing them |
| KR101493508B1 (ko) * | 2013-02-18 | 2015-02-16 | 오스템임플란트 주식회사 | 치아 미백 조성물 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL246462A (fi) * | 1959-08-06 | |||
| GB895050A (en) * | 1960-01-29 | 1962-04-26 | Boehringer & Soehne Gmbh | New basic ethers |
| DE1108684B (de) * | 1960-01-29 | 1961-06-15 | Boehringer & Soehne Gmbh | Verfahren zur Herstellung neuer basischer AEther |
| AT264495B (de) * | 1963-08-18 | 1968-09-10 | Egyt Gyogyszervegyeszeti Gyar | Verfahren zur Herstellung von neuen basischen Cycloheptanoläthern |
| GB1085969A (en) * | 1965-08-11 | 1967-10-04 | Glidden Co | Insectiphobic compositions comprising terpene derivatives |
| US4118499A (en) * | 1975-10-15 | 1978-10-03 | Glaxo Laboratories Limited | Anti-anxiety and anti-parkinsonian 1-aminoalkyl-2-endo-chloro-7,7-dimethylnorbornanes |
| JPS6034925B2 (ja) * | 1979-07-31 | 1985-08-12 | 帝人株式会社 | 持続性鼻腔用製剤およびその製造法 |
-
1979
- 1979-12-14 HU HU79EE2715A patent/HU179164B/hu unknown
-
1980
- 1980-12-09 GB GB8039376A patent/GB2065122B/en not_active Expired
- 1980-12-10 YU YU3111/80A patent/YU42367B/xx unknown
- 1980-12-10 SE SE8008680A patent/SE451132B/sv not_active IP Right Cessation
- 1980-12-10 BE BE1/10069A patent/BE886579A/fr not_active IP Right Cessation
- 1980-12-10 IL IL61685A patent/IL61685A/xx not_active IP Right Cessation
- 1980-12-11 CS CS808736A patent/CS216544B2/cs unknown
- 1980-12-11 JP JP17520880A patent/JPS56123953A/ja active Granted
- 1980-12-11 CH CH9133/80A patent/CH649986A5/de not_active IP Right Cessation
- 1980-12-11 AT AT0601380A patent/AT374449B/de not_active IP Right Cessation
- 1980-12-11 PL PL1980228392A patent/PL127036B1/pl unknown
- 1980-12-11 FR FR8026269A patent/FR2471968B1/fr not_active Expired
- 1980-12-11 NL NL8006722A patent/NL193907C/nl not_active IP Right Cessation
- 1980-12-11 DD DD80225942A patent/DD155320A5/de not_active IP Right Cessation
- 1980-12-11 US US06/215,154 patent/US4342762A/en not_active Expired - Lifetime
- 1980-12-11 DK DK528980A patent/DK156825C/da not_active IP Right Cessation
- 1980-12-11 AU AU65293/80A patent/AU539173B2/en not_active Expired
- 1980-12-11 FI FI803858A patent/FI76783C/fi not_active IP Right Cessation
- 1980-12-12 NO NO803764A patent/NO150638C/no not_active IP Right Cessation
- 1980-12-12 GR GR63641A patent/GR72509B/el unknown
- 1980-12-12 SU SU3219704A patent/SU1253425A3/ru active
- 1980-12-12 IE IE2612/80A patent/IE51733B1/en not_active IP Right Cessation
- 1980-12-12 UA UA3219704A patent/UA5566A1/uk unknown
- 1980-12-12 IT IT8026587A patent/IT1209377B/it active
- 1980-12-12 CA CA000366719A patent/CA1155115A/en not_active Expired
- 1980-12-12 ES ES497717A patent/ES8200857A1/es not_active Expired
- 1980-12-15 DE DE3047142A patent/DE3047142C2/de not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK156825C (da) | Analogifremgangsmaade til fremstilling af en basisk ether eller et farmaceutisk acceptabelt syreadditionssalt eller kvaternaert salt deraf | |
| DK74282A (da) | Fremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK151884C (da) | Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK149942C (da) | Fremgangsmaade til fremstilling af en pasteurellose-vaccine | |
| DK43279A (da) | Fremgangsmaade til fremstilling af 2-penem-3-carboxylsyreforbindelser | |
| DK147362C (da) | Analogifremgangsmaade til fremstilling af ergolen- eller ergolin-derivater eller syreadditionssalte deraf | |
| DK153440C (da) | Fremgangsmaade til fremstilling af et nasalt farmaceutisk ergotpeptidalkaloid-praeparat | |
| DK528879A (da) | Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende isosorbiddinitrat | |
| DK149336C (da) | Fremgangsmaade til fremstilling af antibiotikum a/16686 eller syreadditionssalte deraf | |
| DK149569C (da) | Analogifremgangsmaade til fremstilling af isoquinolineddikesyre-forbindelser eller farmaceutisk acceptable salte deraf | |
| DK157862C (da) | Analogifremgangsmaade til fremstilling af imidazolylphenylamidiner eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK160045C (da) | Analogifremgangsmaade til fremstilling af 4-oxo-4h-pyridooe1,2-aaapyrimidiner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere ammoniumsalte deraf | |
| DK323780A (da) | Fremgangsmaade til fremstilling af substituerede 3-amino-sydnonimider eller farmakologisk acceptable syreadditionssalte deraf | |
| DK302880A (da) | Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende en 3-amino1-aryl-2-pyrazolin | |
| DK8080A (da) | Fremgangsmaade til fremstilling af en graneleret formulering af nabilon | |
| DK158658C (da) | Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf | |
| DK396880A (da) | Fremgangsmaade til fremstilling af cyclohexancarboxylsyrederivater | |
| DK203879A (da) | Fremgangsmaade til fremstilling af en farmaceutisk doseringskomponent | |
| DK154647C (da) | Analogifremgangsmaade til fremstilling af n-oe(4-oe3-substitueret 2-pyridylaapiperazino)butylaaazaspirodecanforbindelser eller et farmaceutisk acceptabelt syreadditionssalt deraf | |
| DK7679A (da) | Fremgangsmaade til fremstilling af et prostaglandinholdigt praeparat | |
| DK149077C (da) | Analogifremgangsmaade til fremstilling af encephalin-analoge pentapeptidamidderivater eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK149625C (da) | Analogifremgangsmaade til fremstilling af n-substituerede (8-halogen- eller -trifluormethyl-4-quinolylamino)-benzamider eller et farmaceutiskacceptabelt syreadditionssalt deraf | |
| DK152427C (da) | Analogifremgangsmaade til fremstilling af 4-thiomethylpyridinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf | |
| DK159435C (da) | Analogifremgangsmaade til fremstilling af 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)benzoesyrederivater eller et farmaceutisk acceptabelt syreadditionssalt deraf | |
| DK162102C (da) | Analogifremgangsmaade til fremstilling af 3-o-(beta-d-glucoronopyranosyl)-sojasapogenol b eller farmaceutisk acceptable salte deraf |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUP | Patent expired |